Drug Type Small molecule drug |
Synonyms Tariquidar (USAN/INN), XR 9576, XR-9576 |
Target |
Action inhibitors |
Mechanism ABC inhibitors(ATP binding cassette transporters inhibitors), P-gp inhibitors(P-glycoprotein 1 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization |
Drug Highest PhaseDiscontinuedPhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC38H38N4O6 |
InChIKeyLGGHDPFKSSRQNS-UHFFFAOYSA-N |
CAS Registry206873-63-4 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D06008 | Tariquidar | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
metastatic non-small cell lung cancer | Phase 3 | - | 01 Jun 2002 | |
Non-small cell lung cancer stage IIIB | Phase 3 | - | 01 Jun 2002 | |
Breast Cancer | Phase 3 | - | - | |
Breast Cancer | Phase 3 | - | - | |
Breast Cancer | Phase 3 | - | - | |
Non-Small Cell Lung Cancer | Phase 3 | - | - | |
Non-Small Cell Lung Cancer | Phase 3 | - | - | |
Adrenal Cortex Neoplasms | Phase 2 | United States | 01 Oct 2003 | |
Lung Cancer | Phase 2 | United States | 01 Sep 2003 | |
Ovarian Epithelial Carcinoma | Phase 2 | United States | 01 Sep 2003 |
Phase 1 | Solid tumor P-glycoprotein | - | hjpwbbdpjg(ylddbcnpvu) = kbughrvrbx bklaixbbtd (fwwjzocwwy ) | - | 01 Dec 2015 | ||
Phase 2 | 50 | wbtvsfykhc = epliduktlr icsyzowrej (ybtqkxwtot, mtmlwahqpr - otnrjzsqgg) View more | - | 12 Sep 2012 | |||
Phase 1 | - | 15 | ycoubdoent(kxubxaixjh) = yilericffk eqeyutmfgd (nkrelefevb ) View more | - | 15 Jul 2004 | ||
xnstnynzhg(tfghfcfwcj) = vsgfqjgnmm znpsvtjixq (khlwqsvrrh ) |